Northern Trust Corp Cassava Sciences Inc Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Cassava Sciences Inc stock. As of the latest transaction made, Northern Trust Corp holds 378,343 shares of SAVA stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

378,343

Previous 378,818 0.13%

Holding current value

$10.2 Million

Previous $7.69 Million 39.21%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.35 - $26.11 $5,866 - $12,402	-475 Reduced 0.13%	378,343 $4.67 Million
Q1 2024 May 14, 2024	SELL	$18.44 - $26.41 $163,157 - $233,675	-8,848 Reduced 2.28%	378,818 $7.69 Million
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $177,364 - $422,503	14,032 Added 3.76%	387,666 $8.73 Million
Q3 2023 Nov 13, 2023	BUY	$16.64 - $25.32 $49,853 - $75,858	2,996 Added 0.81%	373,634 $6.22 Million
Q2 2023 Aug 11, 2023	BUY	$21.59 - $27.88 $220,541 - $284,794	10,215 Added 2.83%	370,638 $9.09 Million
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $184,864 - $287,147	7,880 Added 2.24%	360,423 $8.69 Million
Q4 2022 Feb 13, 2023	SELL	$27.82 - $44.16 $10,961 - $17,399	-394 Reduced 0.11%	352,543 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $88,328 - $276,183	-5,409 Reduced 1.51%	352,937 $14.8 Million
Q2 2022 Aug 12, 2022	SELL	$17.22 - $38.47 $105,834 - $236,436	-6,146 Reduced 1.69%	358,346 $10.1 Million
Q1 2022 May 13, 2022	SELL	$32.6 - $53.05 $499,921 - $813,521	-15,335 Reduced 4.04%	364,492 $13.5 Million
Q4 2021 Feb 08, 2022	SELL	$36.77 - $90.91 $30,445 - $75,273	-828 Reduced 0.22%	379,827 $16.6 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $6.11 Million - $19.8 Million	146,291 Added 62.42%	380,655 $23.6 Million
Q2 2021 Aug 13, 2021	SELL	$32.15 - $89.72 $3.41 Million - $9.51 Million	-105,957 Reduced 31.13%	234,364 $20 Million
Q1 2021 May 12, 2021	SELL	$7.09 - $87.95 $61,661 - $764,901	-8,697 Reduced 2.49%	340,321 $15.3 Million
Q4 2020 Feb 11, 2021	BUY	$6.79 - $12.25 $617,333 - $1.11 Million	90,918 Added 35.23%	349,018 $2.38 Million
Q3 2020 Nov 16, 2020	SELL	$2.86 - $11.51 $19,079 - $76,783	-6,671 Reduced 2.52%	258,100 $2.97 Million
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $466,370 - $2.2 Million	228,613 Added 632.26%	264,771 $815,000
Q1 2020 May 14, 2020	BUY	$3.26 - $9.65 $42,653 - $126,260	13,084 Added 56.7%	36,158 $148,000
Q4 2019 Feb 14, 2020	BUY	$1.1 - $6.12 $5,929 - $32,986	5,390 Added 30.48%	23,074 $120,000
Q3 2019 Nov 13, 2019	SELL	$1.04 - $1.45 $1,040 - $1,450	-1,000 Reduced 5.35%	17,684 $21,000
Q1 2019 May 13, 2019	BUY	$0.92 - $1.29 $17,189 - $24,102	18,684 New	18,684 $24,000

Others Institutions Holding SAVA

# of Institutions

186

Shares Held

13.3M

Call Options Held

1.38M

Put Options Held

2.04M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.08B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cassava Sciences Inc Transaction History